Apex Capital Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q1
$22.3M Buy
199,892
+2,498
+1% +$278K 0.49% 70
2015
Q4
$30.9M Buy
197,394
+476
+0.2% +$74.5K 0.69% 59
2015
Q3
$25.8M Buy
196,918
+7,558
+4% +$992K 0.58% 66
2015
Q2
$32.9M Buy
189,360
+9,234
+5% +$1.61M 0.7% 62
2015
Q1
$31.1M Buy
180,126
+9,097
+5% +$1.57M 0.73% 58
2014
Q4
$22.1M Buy
171,029
+7,793
+5% +$1.01M 0.59% 68
2014
Q3
$21M Buy
163,236
+8,856
+6% +$1.14M 0.63% 65
2014
Q2
$13.7M Buy
154,380
+15,532
+11% +$1.37M 0.42% 74
2014
Q1
$13.1M Sell
138,848
-2,047
-1% -$192K 0.46% 70
2013
Q4
$15.9M Sell
140,895
-141,868
-50% -$16M 0.6% 63
2013
Q3
$22.3M Buy
282,763
+16,180
+6% +$1.28M 0.98% 47
2013
Q2
$17.5M Buy
+266,583
New +$17.5M 0.85% 51